medigraphic.com
ISSN 1527-3172 (Electronic)

2015, Number 4

<< Back Next >>

MEDICC Review 2015; 17 (4)

HIV-1 genetic variability in Cuba and implications for transmission and clinical progression

Blanco AM, Machado ZLY, Díaz TH, Ruiz GN, Romay FD, Silva CE

Language: English
References: 47
Page: 25-31
PDF size: 108.67 Kb.


ABSTRACT

INTRODUCTION Serological and molecular HIV-1 studies in Cuba have shown very low prevalence of seropositivity, but an increasing genetic diversity attributable to introduction of many HIV-1 variants from different areas, exchange of such variants among HIV-positive people with several coinciding routes of infection and other epidemio­logic risk factors in the seropositive population. The high HIV-1 genetic variability observed in Cuba has possible implications for transmission and clinical progression.
OBJECTIVE Study genetic variability for the HIV-1 env, gag and pol structural genes in Cuba; determine the prevalence of B and non-B subtypes according to epidemiologic and behavioral variables and determine whether a relationship exists between genetic variability and transmissibility, and between genetic variability and clinical dis­ease progression in people living with HIV/AIDS.
METHODS Using two molecular assays (heteroduplex mobility assay and nucleic acid sequencing), structural genes were characterized in 590 people with HIV-1 (480 men and 110 women), accounting for 3.4% of seropositive individuals in Cuba as of December 31, 2013. Nonrandom sampling, proportional to HIV prevalence by province, was conducted. Relationships between molecular results and viral factors, host characteristics, and patients' clinical, epidemiologic and behavioral variables were studied for molecular epidemiology, trans­mission, and progression analyses.
RESULTS Molecular analysis of the three HIV-1 structural genes clas­sified 297 samples as subtype B (50.3%), 269 as non-B subtypes (45.6%) and 24 were not typeable. Subtype B prevailed overall and in men, mainly in those who have sex with men. Non-B subtypes were prevalent in women and heterosexual men, showing multiple circulating variants and recombinant forms. Sexual transmission was the predominant form of infection for all. B and non-B subtypes were encountered throughout Cuba. No association was found between subtypes and transmission or clinical progression, although the pro­portion of deaths was higher for subtype B. Among those who died during the study period, there were no differences between subtypes in the mean time from HIV or AIDS diagnosis to death.
CONCLUSIONS Our results suggest that B and non-B HIV-1 sub­types found in Cuba do not differ in transmissibility and in clinical dis­ease progression.


REFERENCES

  1. United Nations. UNAIDS Global Report, UNAIDS Report on the global AIDS Epidemic, 2013 [Internet]. New York: United Nations; 2013 [cited 2013 Jan 11]. Available from: http://www.unaids.org/ en/dataanalysis/knowyourresponse/country progressreports/2013countries/CUB_narrati vereport_2013

  2. Kijak GH, McCutchan FE. HIV diversity, molecular epidemiology and the role of recombination. Curr Infect Dis. 2005 Nov;7(6):480–8.

  3. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, et al. A new human immunodeficiency virus derived from gorillas. Nat Med. 2009 Aug;15(8):871–2.

  4. Nájera R, Delgado E, Pérez L, Thomson M. El papel de la recombinación genética en el desarrollo de la pandemia del sida. Investig Clín Farm. 2005;2(1):9–22. Spanish.

  5. Requejo HI. Worldwide molecular epidemiology of HIV. Rev Saude Publica. 2006 Apr;40(2):331–45.

  6. Díaz HM, Lubian AL, Blanco M, Rolo F, Martínez N, Nibot C. Transmissibility and disease progression in group of individuals infected with different HIV-1 subtypes in Cuba. Proceedings of the 15th International AIDS Conference; 2004 Jul 11–15; Bangkok, Thailand. Bangkok: MEDIMOND International S.r.l. Monduzzi editore; 2004. ISBN 88-7587-065-9.

  7. Rolo FM, Miranda L, Wainberg MA, Gu Z, Lobaina L, Noa E, et al. Envelope V3 region sequences of Cuban HIV-1 isolates. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):123–5.

  8. Gómez CE, Iglesias E, Perdomo W, Rolo F, Blanco M, Lobaina L, et al. Isolates from four different HIV type 1 clades circulating in Cuba. Identified by DNA sequence of the C2–V3 region. AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):55–8.

  9. Cuevas MT, Ruibal I, Villahermosa ML, Díaz HM, Delgado E, Parga EV, et al. High HIV-1 genetic diversity in Cuba. AIDS 2002 Aug;16(12):1643–53.

  10. Pérez L, Thomson M, Bleda MJ. HIV Type 1 Molecular Epidemiology in Cuba: High Genetic Diversity, Frequent Mosaicism, and Recent Expansion of BG Intersubtype Recombinant Forms. AIDS Res Hum Retroviruses 2006; 22 (8):724–33.

  11. Resik S, Lemey P, Ping LH, Kouri V, Joanes J, Pérez J, et al. Limitations to contact tracing and phylogenetic analysis in establishing HIV type 1 transmission networks in Cuba . AIDS Res Hum Retroviruses. 2007 Mar;23(3):347–56.

  12. Pérez L, Alvarez LP, Carmona R, Aragonés C, Delgado E, Thomson MM, et al. Genotypic resis tance to antiretroviral drug in patients infected with several HIV type 1 genetic forms in Cuba. AIDS Res Hum Retroviruses. 2007 Mar;23(3):407–14.

  13. Machado LY, Blanco M, Dubed M, Díaz HM, Ruiz NM, Váldes N, et al. HIV type 1 genetic diversity in newly diagnosed Cuban patients. AIDS Res Hum Retroviruses. 2012 Aug;28(8):956–60.

  14. Machado LY, Dubed M, Díaz H, Ruiz N, Romay D, Váldes N, et al. Transmitted HIV type 1 drug resis tance in newly diagnosed Cuban patients. AIDS Res Hum Retroviruses. 2013 Feb;29(2):411–4.

  15. Kanki PJ, Peeters M, Guéye-Ndiaye A. Virology of HIV-1 and HIV-2: implications for Africa. AIDS. 1997;11 Suppl B:S33–42.

  16. Rosner B, Rosner R. Fundamentals of biostatistics. 5th ed. Massachusetts: Duxbury Press; 1999.

  17. Boyum A. Isolation of mononuclear cells and gran ulocytes from human blood. Isolation of monucle ar cells by one centrifugation, and granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89.

  18. Jackson DP, Hayden JD, Quirke P. Extraction of nucleic acid from fresh and archival material. In: McPherson MJ, Quirke P, Taylor GR, editors. PCR: A Practical Approach Series. Oxford: IRL Press; 1991. 280 p.

  19. Powell RL, Urbanski MM, Nyambi PN. A heteroduplex assay for the rapid detection of dual Human Immunodeficiency Virus Type 1 infections. J Virol Methods. 2008 Apr;149(1):20–7.

  20. Manigart O, Boeras DI, Karita E, Hawkins PA, Vwalika C, Makombe N, et al. A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission pairs. AIDS Res Hum Retroviruses. 2012 Dec;28(12):1745–55.

  21. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplexmobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cit ies. J Virol. 2000 Jan;74(1):363–70.

  22. Thomson M, Casado G, Posada D, Sierra M, Nájera R. Identification of novel complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba. AIDS. 2005 Jul 22;19(11):1155–63.

  23. Quarleri JF, Rubio A, Carobene M, Turk G, Vignoles M, Harrigan RP, et al. HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure. AIDS Res Hum Retroviruses. 2004 Oct;20(10):1100–7.

  24. Los Álamos National Laboratory database [Internet]. Los Álamos: Los Álamos National Laboratory (US); c2006–2009. HIV Databases; [updated 2015 Jun; cited 2013 Jan 11]. Available from: www.hiv.lanl.gov

  25. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007 Aug;24(8):1596–9.

  26. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980 Dec;16(2):111–20.

  27. Aragonés C, Campos JR, Pérez D, Martínez A, Pérez J. SIDATRAT: Informatics to improve HIV/ AIDS care. MEDICC Rev. 2012 Oct;14(4):5–9.

  28. Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, et al. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/ mm3: assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011 Oct;53(8):817–25.

  29. Armitage P, Armitage EN, Berry G. Estadística para la investigación biomédica. 2nd ed. Barcelona: Doyma Press; 1992. Spanish.

  30. Kapaata A, Lyagoba F, Ssemwanga D, Magambo B, Nanyonjo M, Levin J, et al. HIV-1 subtype dis tribution trends and evidence of transmission clus ters among incident cases in a rural clinical cohort in southwest Uganda, 2004–2010. AIDS Res Hum Retroviruses. 2013 Mar;29(3):520–7.

  31. Huang A, Hogan JW, Istrail S, Delong A, Katzenstein DA, Kantor R. Global analysis of sequence diversity within HIV-1 subtypes across geographic region. Future Virol. 2012 May;7(5):505–17.

  32. Kouyos RD, von Wyl V, Yerly S, Böni J, Taffé P, Shah C, et al. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis. 2010 May 15;201(10):1488–97.

  33. Jennes W, Kyongo J , Vanhommerig E, Camara E, Coppens S, Seydi M. Molecular Epidemiology of HIV-1 Transmission in a Cohort of HIV-1 Concordant Heterosexual Couples from Dakar, Senegal. PLoS One 2012;7(5):e37402. DOI:10.1371/ journal.pone.0037402

  34. Yebraa G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, et al. Sensitivity of seven HIV subtyping tools differs among sub types/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antiviral Res. 2011 Jan;89(1):19–25.

  35. Ssemwanga D, Nsubuga RN, Mayanja BN, Lyagoba F, Magambo B, Yirrell D, et al. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study. PLoS One. 2013 Aug 12;8(8):e71768. DOI: 10.1371/ journal.pone.0071768.

  36. Gorry C. Cuba’s National HIV/AIDS Program. MEDICC Rev. 2011 Apr;13(2):5–8.

  37. Zhang X, Wang C, Hengwei W, Li X, Li D, Ruan Y, et al. Risk factors of HIV infection and prevalence of co-infections among men who have sex with men in Beijing, China. AIDS. 2007 Dec;21 Suppl 8:S53–7.

  38. Chun HM, Carpenter RJ, Macalino GE, Crum- Cianflone NF. The role of sexually transmitted infections in HIV-1 progression: a comprehensive review of the literature. J Sexually Transmitted Dis [Internet]. 2013 [cited 2014 Feb 15]; [about 16 p]. Available from: http://downloads.hindawi .com/journals/jstd/2013/176459.pdf

  39. Keller M, Lu Y, Lalonde R, Klein M. Slower clinical progression in antiretroviral-naïve African immi grants compared to Haitian and Canadian patients in a universal health care system. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections; 2008 Feb 3–6; Bos ton, Massachusetts. Abstract 528.

  40. Goetz MB, Leduc R, Kostman JR, Labriola AM, Lie Y, Weidler J, et al. Relationship between HIV core ceptor tropism and disease progression in per sons with untreated chronic HIV infection. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):259–66.

  41. Castro-Nallar E, Crandall K, Pérez-Losada M. Genetic diversity and molecular epidemiology of HIV transmission. Future Virol. 2012;7(3):239– 52.

  42. Kouyos RD, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, et al. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis. 2011 Feb 15;52(4):532–9.

  43. Sharp PM, Hahn B. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci. 2010 Aug 27;365(1552):2487–94.

  44. Easterbrook P, Smith M, Mullen J, O´Shea S, Chrystie I, de Ruiter A, et al. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc. 2010 Feb 3;13:4. DOI: 10.1186/1758-2652-13-4.

  45. Araujo AF, Brites C, Monteiro-Cunha J, Santos LA, Galvao-Castro B, Alcántara L. Lower prevalence of human immunodeficiency virus type 1 Brazilian subtype B found in Northeastern Brazil with slower progression to AIDS. AIDS Res Hum Retroviruses 2010;26(11):1249–54.

  46. Manak M, Sina S, Anekella B, Hewlett I, Sanders-Buell E, Ragupathy V, et al. Pilot Studies for Development of an HIV Subtype Panel for Surveil lance of Global Diversity. AIDS Res Hum Retrovi ruses. 2012 Jun;28(6):594–606.

  47. Daar ES, Kesler KL, Wrin T, Petropoulo CJ, Bates M, Lail A, et al. HIV-1 pol replication capacity predicts disease progression. AIDS. 2005 Jun 10;19(9):871–7.




2020     |     www.medigraphic.com